Masimo starts public life with sharp rise:

Executive Summary

Pulse oximetry company Masimo has closed its initial public offering of around 12 million shares and began life on the Nasdaq on August 8. The Irvine, California-based firm saw its share price increase by 9% on the first day of trading to $20.90 per share from $19 per share. The company has sustained this high rise since, as shares were priced at $21 at the close of markets on August 13. Masimo intends to use proceeds from the IPO to further commercialisation of its Masimo SET and Masimo Rainbow SET products - monitoring technologies which the company claims are proven to allow clinicians to accurately monitor blood oxygen saturation in critical situations by clinical and laboratory studies.